2023心脏瓣膜病领域治疗进展 .pdfVIP

2023心脏瓣膜病领域治疗进展 心脏瓣膜病（VHD ）是全球心血管疾病发病和死亡的主要来源。近年 来，心脏瓣膜病领域取得了众多进展， 包括房颤对瓣膜疾病发展和评 估影响的认识、风湿性心脏病的全球预防策略、继发性二尖瓣反流 （SMR ）的理解和管理、二叶式主动脉瓣（BAV ）疾病的管理、与中 度主动脉瓣狭窄（AS ） 关的心血管风险增加，以及越来越多的经导 管治疗手段。本文主要对VHD领域 关新进展进行介绍，以飨读者。 ATRIAL FIBRILLATION SECONDARY MITRAL REGURGITATION AORTIC VALVE DISEASE • CaumI in mitul 4nd rccurQitJti n • Heter gcne u$ mechanisms (gl bal ・ Increased cdrdi vMCuUr risk ass ciated • C ns^Que ct f pr Qmsiv? valvuiar disease versus segmental left ventricle with m derate a rtk sten sis • Results in under f a rtK stm sts dilatati n and dysfuncti n) ・ Outc tnes f transcatheter a ctk valve • Central r le f medkdl therapy implantati n (TAVT) in treatrnent f m derate • Ass c idt^d wtth incrcds^d rrxxtdlity with a rtic sten sis and c existent heart failure c 6xt$t^nt valvular d兴•建 • Devel p ng r les f edge-t -edge repair and (ranKdthet^r mitral impUntati n ・ R le f TAVI in bkuvpid d rtk vMve disease and n ncakified a rtk regurgitati n TRANSCATHETER FMITRAL THERAPIES TRICUSPID REGURGITATION ・ Optimal patient setectn n, durability, and • Timing and patient selecti n f r interventi n mand96n€ t f r^cutfi ?nt rWtfdl • Patient selecti n f r transcathetef repair r^auraitdti n after eda et cdge repair versus replacement ・ Feasibility and utc me es f • Outc me f transcatbeter trkuspid repair r trA scdthctcf mitral chiOfdAl repair repixement c tnpar^d with rr^cdicdl th^edpy ・ R le ( tran